Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals

被引:216
作者
Kern, F
Bunde, T
Faulhaber, N
Kiecker, F
Khatamzas, E
Rudawski, IM
Pruss, A
Gratama, JW
Volkmer-Engert, R
Ewert, R
Reinke, P
Volk, HD
Picker, LJ
机构
[1] Charite, Inst Med Immunol, D-10098 Berlin, Germany
[2] Charite, Med Klin Schwerpunkt Nephrol & Intens Med, D-10098 Berlin, Germany
[3] Charite, Inst Transfus Med, D-10098 Berlin, Germany
[4] Deutsch Herzzentrum Berlin, Berlin, Germany
[5] Univ Rotterdam Hosp, Dr Daniel den Hoed Canc Ctr, Dept Internal Oncol, Lab Clin & Tumor Immunol, Rotterdam, Netherlands
[6] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA
关键词
D O I
10.1086/340637
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen-specific, cytokine flow cytometry was used to analyze the prevalence and frequency of CD4 and CD8 memory T cells specific for the abundantly expressed cytomegalovirus (CMV) phosphoprotein 65 (pp65) in healthy CMV IgG-seropositive individuals. Stimulation of peripheral blood mononuclear cells with peptide pools and individual peptides derived from the pp65 amino acid sequence in 40 donors revealed that 63% of donors had a detectable CD4 T cell response and that 83% of donors had a detectable CD8 T cell response against this protein. The overall frequencies of T cells directed against pp65 were analyzed for 20 donors by stimulation with peptide pools covering the complete pp65 protein and were as high as 2 in 1000 and 9 in 1000 (median) peripheral blood CD4 and CD8 T cells, respectively. In addition, a comparison between CD4 responses to a CMV lysate containing various CMV proteins and pp65-specific responses in 9 donors indicated that pp65 was a dominant target of the CMV-specific CD4 T cell response in some, but not all, donors. Several new T cell epitopes were identified.
引用
收藏
页码:1709 / 1716
页数:8
相关论文
共 36 条
  • [1] FINE SPECIFICITY OF CELLULAR IMMUNE-RESPONSES IN HUMANS TO HUMAN CYTOMEGALOVIRUS IMMEDIATE-EARLY 1-PROTEIN
    ALP, NJ
    ALLPORT, TD
    VANZANTEN, J
    RODGERS, B
    SISSONS, JGP
    BORYSIEWICZ, LK
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (09) : 4812 - 4820
  • [2] Altman JD, 1998, SCIENCE, V280, P1821
  • [3] COMPARATIVE-ANALYSIS OF 14 INDIVIDUAL HUMAN CYTOMEGALOVIRUS PROTEINS FOR HELPER T-CELL RESPONSE
    BENINGA, J
    KROPFF, B
    MACH, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 153 - 160
  • [4] Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus
    Bitmansour, AD
    Waldrop, SL
    Pitcher, CJ
    Khatamzas, E
    Kern, F
    Maino, VC
    Picker, LJ
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1151 - 1163
  • [5] HUMAN CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC T-CELLS - RELATIVE FREQUENCY OF STAGE-SPECIFIC CTL RECOGNIZING THE 72-KD IMMEDIATE EARLY PROTEIN AND GLYCOPROTEIN-B EXPRESSED BY RECOMBINANT VACCINIA VIRUSES
    BORYSIEWICZ, LK
    HICKLING, JK
    GRAHAM, S
    SINCLAIR, J
    CRANAGE, MP
    SMITH, GL
    SISSONS, JGP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) : 919 - 931
  • [6] CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125
  • [7] Anti-human cytomegalovirus activity of cytokines produced by CD4(+) T-cell clones specifically activated by IE1 peptides in vitro
    Davignon, JL
    Castanie, P
    Yorke, JA
    Gautier, N
    Clement, D
    Davrinche, C
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (04) : 2162 - 2169
  • [8] CYTOMEGALOVIRUS REACTIVATION AND TUMOR-NECROSIS-FACTOR
    DOCKE, WD
    PROSCH, S
    FIETZE, E
    KIMEL, V
    ZUCKERMANN, H
    KLUG, C
    SYRBE, U
    KRUGER, DH
    VONBAEHR, R
    VOLK, HD
    [J]. LANCET, 1994, 343 (8892) : 268 - 269
  • [9] DEVELOPMENT OF A TREATMENT REGIMEN FOR HUMAN CYTOMEGALOVIRUS (CMV) INFECTION IN BONE-MARROW TRANSPLANTATION RECIPIENTS BY ADOPTIVE TRANSFER OF DONOR-DERIVED CMV-SPECIFIC T-CELL CLONES EXPANDED INVITRO
    GREENBERG, PD
    REUSSER, P
    GOODRICH, JM
    RIDDELL, SR
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1991, 636 : 184 - 195
  • [10] Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly
    Hengel, H
    Flohr, T
    Hammerling, GJ
    Koszinowski, UH
    Momburg, F
    [J]. JOURNAL OF GENERAL VIROLOGY, 1996, 77 : 2287 - 2296